Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Licenses Patents to Invitrogen for Manufacture of Nucleic Acid Arrays

NEW YORK (GenomeWeb News) - Affymetrix and Invitrogen said today that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents.
Under the agreement, Invitrogen will now be allowed to "manufacture and sell spotted nucleic acid microarrays in the research field," the companies said. Financial details of the license were not disclosed.
 
The licensing deal is the third in seven months for Affy. In April, the microarray company licensed patents to Abbott Laboratories to enable it to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.
 
Last December, Affy licensed an undisclosed number of patents to Applied Biosystems related to the manufacture, sale, and use of microarrays for gene expression analysis.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.